The Effect of Intranasal Olopatadine Hydrochloride on Influenza A and B Symptoms In Children: A Clinical Observation and Comparative Evaluation
Yazarlar (1)
| Makale Türü | Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri) (Diğer hakemli ulusal dergilerde yayınlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale) | ||
| Dergi Adı | Chron Precis Med Res | ||
| Dergi ISSN | 2757-6124 | ||
| Dergi Tarandığı Indeksler | Index Copernicus, OpenAIRE, Google Scholar and EuroPub | ||
| Makale Dili | İngilizce | Basım Tarihi | 07-2025 |
| Cilt / Sayı / Sayfa | 6 / 2 / 48–51 | DOI | 10.5281/zenodo.16585082 |
| Makale Linki | https://chronpmr.com/index.php/cpmr/issue/view/30 | ||
| UAK Araştırma Alanları |
Çocuk Sağlığı ve Hastalıkları (Çocuk Sağlığı ve Hastalıkları)
|
||
| Özet |
| Aim: This study aims to evaluate the effects of intranasal Olopatadine Hydrochloride on nasal and systemic symptoms in pediatric patients diagnosed with influenza A or B infection. Material and Method: Children aged 6-18 years who presented to the Pediatric Outpatient Clinics of Health Sciences University Prof. Dr. Cemil Taşcıoğlu City Hospital and Yalova Training and Research Hospital between 1 January and 15 March 2025 and were diagnosed with influenza A or B were retrospectively evaluated. Patients (n= 50) who received appropriately dosed intranasal Olopatadine Hydrochloride alongside symptomatic treatment underwent face-to-face interviews regarding their previous treatment experience, including symptom profiles and duration.Results: In the influenza A-positive group (n= 25), the duration of nasal congestion was 2 days in the group receiving intranasal Olopatadine Hydrochloride (n= 13) versus 6 days in the group receiving no Olopatadine Hydrochloride (n= 12). Sneezing lasted 1 day in the Olopatadine group and 7 days in the group receiving no Olopatadine. No significant differences were observed in systemic symptoms. A significant reduction in the duration of nasal congestion and sneezing was observed in the Olopatadine group (p< 0.001). In the influenza B-positive group (n= 25), nasal congestion lasted 1 day in the Olopatadine group (n= 13) and 3 days in the other group (n= 12). Sneezing lasted 1 day in the Olopatadine group and 4 days in the other. Again, there were no significant differences in systemic symptoms. A significant reduction in nasal congestion and sneezing duration was observed in the Olopatadine … |
| Anahtar Kelimeler |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Google Scholar | 2 |